pH值对日本三角涡虫种群增长、无性生殖及6种酶活力的影响

应用种群累积培养法,就培养液的pH值对日本三角涡虫的生存、种群增长、无性生殖以及涡虫超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-PX)、乳酸脱氢酶(LDH)、Na -K -ATP酶和Ca2 -Mg2 -ATP酶等6种酶活力的影响进行了探讨.结果表明,涡虫存活的pH上限为11.0,下限为3.0,涡虫存活的最适pH范围为4.5-8.5;pH值对涡虫种群增长有显著影响,种群密度及种群瞬时增长率均随pH的不同而明显改变.培养27d后,pH 4.0-9.0时涡虫种群为正增长:pH 4.5-6.5时,涡虫种群密度最高,pH 7.5-8 .5时次之,pH 7.0时较低,pH 4.0和9.0时最低;而pH 9.5时为负增长.当pH值偏离7.0(偏酸或偏碱)时CAT、GSH-PX、Na -K -ATP酶和Ca2 -Mg2 -ATP酶活力整体均呈现增加的趋势,而SOD和LDH活力整体呈下降趋势.pH值偏离7.0(偏酸或偏碱)时涡虫6种酶活力均产生明显的变化,这与pH 4.5-6.5和pH 7.5-8.5时涡虫具有比pH 7.0实验组涡虫较高的无性横裂生殖率之间可能存在一定的内在联系.本文研究结果可为实验室培养日本三角涡虫提供适宜的pH值指标.     

安宫牛黄丸药效组分对内毒素损伤小鼠脑组织ATP酶活性的影响

目的:观察安宫牛黄丸药效组分对内毒素损伤小鼠脑组织ATP酶活性的影响。方法:腹腔注射脂多糖制备内毒素损伤小鼠模型,利用比色方法测定安宫牛黄丸药效组分对模型小鼠脑组织Na+-K+-ATP酶、Ca2+-Mg2+-ATP酶的影响。结果:安宫牛黄丸药效组分可显著提高内毒素损伤小鼠脑组织Na+-K+-ATP酶及Ca2+-Mg2+-ATP酶活性,与安宫牛黄丸具有等效性。结论:安宫牛黄丸药效组分可使脑组织ATP酶活性升高,在安宫牛黄丸改善脑损伤、促清醒中发挥积极作用。     

恒定磁场对日本三角涡虫无性横裂生殖及2种抗氧化酶活力的影响

目的:探讨恒定磁场对日本三角涡虫(Dugesia japonica)无性横裂生殖及抗氧化酶活力的影响.方法:应用种群累积培养法,观察了恒定磁场对日本三角涡虫的种群增长、无性横裂生殖及涡虫体内超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活力的影响.结果:场强大小在200mT-500mT范围的恒定磁场能促进涡虫的无性横裂生殖,但恒定磁场显著抑制涡虫的SOD及CAT活力.结论:日本三角涡虫对恒定磁场的生理学响应较为敏感,可作为生物磁学研究适宜的实验材料.     

脑益康对D-半乳糖和亚硝酸钠所致Alzheimer病小鼠模型的保护作用

目的:探讨脑益康(中药)对D-半乳糖(D-gal)和亚硝酸钠(NaNO2)所致阿尔茨海默病(AD)小鼠模型的保护作用.方法:采用D-gal和NaNO2腹腔注射建立AD小鼠模型.应用迷宫刺激器检测小鼠学习记忆能力,生化方法检测小鼠脑组织一氧化氮(NO)含量和单胺氧化酶-B(MAO-B)、谷胱甘肽过氧化物酶(GSH-PX)、Na -K -ATP酶及Ca2 -ATP酶活性; RT-PCR检测凋亡调控基因Bax、Bcl-2 mRNA表达情况.结果:脑益康(中药)能改善小鼠学习记忆能力,降低AD小鼠脑组织MAO-B活性,升高Na -K -ATP酶和Ca2 -ATP酶活性,抑制Bax mRNA的表达,上调Bcl-2 mRNA的表达.结论:脑益康(中药)对AD小鼠有一定保护作用,其机制可能与降低脑组织MAO-B活性,提高脑组织Na -K -ATP酶和Ca2 -ATP酶活性,调节Bcl-2 mRNA和Bax mRNA的表达,发挥抗氧化作用,减轻神经细胞损伤有关.     

参附注射液对心肌缺血/再灌注损伤血流动力学和心肌酶的影响

目的：探讨参附注射液对家兔心肌缺血/再灌注（I/R）损伤的保护作用及其机制。方法：家兔30只,随机分为3组（n=10）：对照组、心肌缺血/再灌注损伤（MI/RI）组和参附注射液组,统一标准喂养。行药物预处理10 min后,手术结扎家兔冠状动脉左心室支,建立急性心肌缺血再灌注模型,观察急性心肌缺血和再灌注状态下血流动力学及心肌组织中酶的变化。结果：与对照组比较：MI/RI组心脏舒缩功能减退,丙二醛（MDA）含量增高,超氧化物歧化酶（SOD）、谷光甘肽过氧化物酶（GSH-PX）和细胞能源Na＋-K＋-ATP酶及Ca2＋-ATP酶活性降低,乳酸脱氢酶（LDH）、肌酸激酶（CK）大量释放。而与MI/RI组比较：参附注射液组能不同程度的恢复左心室收缩压（LVSP）、心室内压最大变化速率（±dp/dtmax）（P〈0.01）,降低左室舒张末期压（LVEDP）（P〈0.01）,抑制MDA、LDH、CK升高,增强SOD、GSH-PX、Na＋,K＋-ATP及Ca2＋-ATP活力。结论：参附注射液对心肌缺血/再灌注损伤具有明显的保护作用。     

甘草黄酮对长期大强度运动小鼠心肌损伤的保护作用

为了探讨甘草黄酮对长期大强度运动小鼠心肌损伤的保护作用机制。本研究选用50只昆明雄性小鼠为研究对象,以每组10只分组,分为安静对照组(A组)、运动训练组(B组)、运动低剂量给药组(C组)、运动中剂量给药组(D组)、以及运动高剂量给药组(E组)。运动低剂量给药组(C组)、运动中剂量给药组(D组)、运动高剂量给药组(E组)训练前分别灌服剂量为5 g/kg/d、10 g/kg/d、15 g/kg/d黄酮溶液;除安静对照组外,运动组小鼠进行为期6周的大强度游泳训练。测定小鼠各组小鼠血清CK-MB、c Tn I,心肌组织中GSH-PX、SOD、CAT、MDA、NOS、NO、Na+/K+-ATP、Ca2+/Mg2+-ATP。结果表明:与安静对照组比较,运动训练组CK-MB、c Tn I、MDA、NO、NOS升高,GSH-PX、SOD、CAT、Na+/K+-ATP、Ca2+/Mg2+-ATP降低。与运动训练组比较,运动低剂量给药组、运动中剂量给药组、运动高剂量给药组CK-MB、c Tn I、MDA、NO、NOS降低,GSH-PX、SOD、CAT、Na+/K+-ATP、Ca2+/Mg2+-ATP升高;与运动低剂量给药组比较,运动高剂量给药组CK-MB、c Tn I、GSH-Px、SOD、Na+/K+-ATP、Ca2+/Mg2+-ATP升高,MDA降低。本研究提示,长期大强度运动导致机体心肌损伤,甘草黄酮可提高机体心肌组织中抗氧酶、ATPase酶的活性,抑制自由基生成、NOS活性,减少NO的生成,维持细胞膜内外Na+、K+、Ca2+、Mg2+的分布平衡,对大强度运动造成的心肌损伤具有保护作用,效果以高剂量黄酮最佳。     

N,N-二甲基乙酰胺对东亚三角涡虫(Dugesia japonica)毒性效应的研究

N,N-二甲基乙酰胺(DMA)的大量应用导致其越来越多的进入环境.然而水环境中的DMA对水生生物的毒性尚不明确.通过急毒性、再生、抗氧化酶活力及彗星电泳试验.探讨DMA对东亚三角涡虫(Dugesia japonica)的毒性作用.研究发现,DMA处理涡虫24、48、72、96 h的半致死浓度(LC50)分别为27.7、18.4、10.7、6.7 g/L;浓度大于0.9 g/L的DMA会损伤再生组织,延缓涡虫完成再生;处理48 h后,DMA浓度为0～5 g/L时,涡虫体内过氧化物歧化酶(SOD)及谷胱甘肽过氧化物酶(GSH-PX)活力呈上升趋势,大于5 g/L时酶活力开始下降,而过氧化氢酶(CAT)活力在DMA浓度小于1 g/L时呈下降趋势,大于1 g/L后呈现上升趋势;DMA对涡虫DNA的损伤作用不明显,浓度达到10 g/L后才表现出遗传毒性(P<0.05).结果表明DMA对涡虫有明显的生物毒性,同时涡虫对DMA毒性的反应灵敏,可用于监测水环境DMA污染.     

山药多糖对老年性痴呆小鼠抗氧化能力的影响

目的:探讨山药多糖对老年性痴呆小鼠抗氧化能力的影响。方法:采用三氯化铝复制痴呆小鼠模型,将50只昆明种小鼠随机分5组(n=10):对照组、模型组和山药多糖低、中、高剂量组,山药多糖剂量分别为100 mg/kg·d、300 mg/kg·d、500 mg/kg·d。治疗组用不同剂量山药多糖分别灌胃90 d。测定小鼠脑系数、脑组织丙二醛(MDA)含量、Na+-K+-ATP酶和Mg2+-ATP酶活性,以及血清氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性。结果:山药多糖能显著提高痴呆模型小鼠脑系数、Na+-K+-ATP酶和Mg2+-ATP酶活性、以及SOD和CAT活力;显著降低MDA含量。结论:增强脑组织ATP酶活性和提高机体抗氧化能力可能是山药多糖防治老年性痴呆的作用机制之一。     

辣椒素对肾脏缺血再灌注损伤的保护作用及TRPV1通路相关性研究

研究辣椒素的抗肾脏缺血再灌注损伤(I/R)的作用及可能的作用机制。将SD大鼠随机分为假手术组、模型组、低剂量辣椒素组(4μg/kg)、中剂量辣椒素组(8μg/kg)、和高剂量辣椒素组(16μg/kg)。辣椒素组在缺血前45分钟通过腹腔注射(4、8、16)μg/kg的辣椒素,辣椒素组在缺血前45分钟通过腹腔注射(4、8、16)μg/kg的辣椒素,假手术组和模型组在缺血前45分钟通过腹腔注射等体积生理盐水。利用ELISA检测血清中肌酐(Cr)和尿素氮(BUN)的含量;过碘酸雪夫染色(PAS)染色检测肾组织病理形态;酶法检测肾脏线粒体Ca2+-ATP酶和Na+-K+-ATP酶活性;硫代巴比妥酸比色法(TBA)检测肾脏线粒体丙二醛(MDA)的含量;黄嘌呤氧化酶法检测肾脏线粒体超氧化物歧化酶(SOD)活性;比色法检测肾脏线粒体谷胱甘肽过氧化物酶(GPx)和过氧化氢酶(CAT)活性;免疫蛋白印记法(Western bloting)检测瞬时感受器电位香草酸受体-1 (Transient Receptor Potential Vanilloid-1,TRPV1)和p-TRPV1蛋白水平;高效液相色谱法检测肾脏线粒体三磷酸腺苷(ATP)、二磷酸腺苷(ADP)、一磷酸腺苷(AMP)含量,并计算和腺苷酸池(ATP+ADP+AMP)含量。结果显示:与假手术组相比,模型组Cr、BUN和线粒体MDA的含量以及p-TRPV1表达水平和肾组织病理损伤均明显增加,而线粒体SOD、GPx、CAT、Ca2+-ATP酶和Na+-K+-ATP酶活性以及ATP、ADP、AMP和ATP+ADP+AMP含量均明显降低,而TRPV1表达无差异;与模型组相比,利用辣椒素预处理可呈剂量依赖性减少Cr、BUN和线粒体MDA的含量以及肾组织病理损伤,并可呈剂量依赖性增加肾脏线粒体SOD、GPx、CAT、Ca2+-ATP酶和Na+-K+-ATP酶活性以及p-TRPV1表达和ATP、ADP、AMP和ATP+ADP+AMP含量,而TRPV1表达无差异;以上结果均表明辣椒素减轻大鼠肾缺血再灌注损伤与抑制线粒体脂质过氧化反应相关。     

急性颅脑损伤大鼠脑组织ATP酶活性及TNF-α的变化及意义

目的 观察大鼠急性颅脑损伤后脑组织ATP酶活性及肿瘤坏死因子-α（TNF-α）的变化,探讨急性颅脑损伤后脑水肿的发病机制.方法 将72只SD大鼠随机分为正常组（N组）、假手术对照组（S组）、急性颅脑损伤模型组（ACI组）,其中S组和ACI组于造模后分为2、6、24、72 h时间点,每个时间点8只大鼠;取大鼠伤灶区脑组织测定Na＋-K＋-ATP酶和Ca2＋-ATP酶活性、TNF-α含量及脑组织含水量.结果 急性颅脑损伤后脑组织Na＋-K＋-ATP酶、Ca2＋-ATP酶活性降低（P〈0.05）,TNF-α含量升高（P〈0.05）;颅脑损伤后24 h脑水肿较严重.相关性分析提示,Ca2＋-ATP酶活性与TNF-α含量呈负相关（P〈0.05）.结论 急性颅脑损伤后可引起脑组织ATP酶活性降低、TNF-α含量增加,两者可能协同参与了急性颅脑损伤后脑水肿.     

D-半乳糖致衰老模型大鼠肝肾功能和自由基代谢与中药的干预作用

目的观察D-半乳糖致衰老模型大鼠血糖血脂、肝肾功能和自由基代谢的变化,探讨中药的干预作用及其抗衰老的机制。方法大鼠每日皮下注射D-半乳糖,连续造模7周,建立大鼠衰老模型,造模同时,用抗衰老片和首乌延寿片进行干预,测定试验大鼠的血糖血脂、肝肾功能和SOD、MDA、Na＋-K＋-ATPase和Ca＋＋-Mg＋＋-ATPase等自由基代谢指标。结果造模7周后,模型对照组衰老大鼠TG、BUN明显升高（P〈0.05,P〈0.01）,AST、ALP、CREA呈上升趋势（P〉0.05）,肝、肾组织SOD活性明显降低（P〈0.05）,肾组织MDA含量明显升高（P〈0.05）,肝组织Na＋-K＋-ATPase和Ca＋＋-Mg＋＋-ATPase活性均显著降低（P〈0.05,P〈0.01）;给予抗衰老片和首乌延寿片后,衰老大鼠TG、AST、BUN、CREA和UA均显著降低（P〈0.05,P〈0.01）,肝、肾组织MDA含量显著降低（P〈0.05）,SOD活性显著升高（P〈0.05,P〈0.01）,肝组织Na＋-K＋-ATPase和Ca＋＋-Mg＋＋-ATPase活性均显著升高（P〈0.01）。结论D-半乳糖致衰老大鼠模型的血脂上升、肝肾功能异常和抗脂质过氧化的能力下降;给予抗衰老片和首乌延寿片后,可有效改善衰老大鼠的糖脂代谢和肝肾功能,提高肝肾组织的抗脂质过氧化的能力,提示中药的抗衰老作用可能与其抗氧化作用有关。     

11,12.环氧二十碳三烯酸预处理与后处理对缺血/再灌注大鼠心肌的保护作用

采用Langendorff离体灌流装置,通过停灌40 min/复灌30 min复制大鼠心肌缺血/再灌注(ischemia/reperfusion,IR)损伤模型,观察11,12-环氧二十碳三烯酸(11,12-epoxyeicosatrienoic acid,11,12-EET)预处理和后处理对心肌线粒体功能以及心功能的影响,探讨11,12-EET顸处理和后处理对IR大鼠心肌的作用及其机制.将30只Sprague-Dawley大鼠随机分为对照组、IR组、EET预处理组(Pre-EET)、EET后处理组(Post-EET),每组6只.除对照组外,其它各组全心缺血40 min,再灌注30 min.监测左心室内压差(ALVP)和左心室内压升降的最大变化率(±dp/dtmax)等心功能指标,测定灌流液中乳酸脱氢酶(1actate dehydrogenase,LDH)的活性.灌流结束后,测定心肌线粒体琥珀酸脱氢酶(succinate dehydrogenase,SDH)、Ca"ATPase、Na - K -ATPase活性以及心肌超氧化物歧化酶(superoxide dismutase,SOD)活性、丙二醛(malondialdehyde,MDA)含量.结果显示:(1)与IR组相比,Pre-EET组及Post.EET组Na -K -ATPase和SDH活性均增强,Ca2 -ATPase活性均减弱,有显著性差异(P<0.05);而Pre-EET与Post-EET组间没有显著性差异.(2)与IR组相比,Pre-EET组及Post-EET组心功能明显改善,LDH漏出显著减少,心肌SOD活性明显增强,MDA含量明显降低,有显著性差异(P<0.05);而Pre-EET与Post-EET组间没有显著性差异.结果表明,11,12-EET预处理及后处理均可通过上调心肌线粒体Na -K -ATPase、SDH活性以及下调Ca2 -ATPase活性改善线粒体功能和心肌能量代谢,拮抗心肌IR损伤;11,12-EET预处理及后处理还可通过提高心肌SOD活性、降低MDA含量改善IR心肌的氧化应激.     

粉防已碱与红细胞膜ATPase相互作用的研究

粉防已碱是一种新的钙调蛋白拮抗剂,专一性抑制人红细胞膜上依赖CaM的Ca~(2+)-Mg~(2+)-ATPase。在较高浓度下,它也不同程度地抑制Ca~(2+)-Mg~(2+)-ATPase基本活性、Na~+-K~+-ATPase和Mg~(2+)-ATPase的活性。 除CaM外,不饱和脂肪酸和有限水解均导致膜Ca~(2+)-Mg~(2+)-ATPase的活化,所有这些活化作用被Tet在大约相同的浓度范围内抑制,表明Tet除与CaM结合外,也与膜Ca~(2+)-Mg~(2+)-ATPase结合。 Tet具有抗抵渗溶血的性能,反映了拮抗CaM与药物的膜稳定性间存在相关性。     

Goat erythrocyte calmodulin is not abnormal

Calmodulin was purified from goat erythrocyte hemolysate using heat treatment and Sephadex G-100 gel filtration chromatography. The molecular weight and Stokes, radius of the purified calmodulin was determined. The goat erythrocyte calmodulin stimulated (Ca(2+)-Mg2+)-ATPase but not (Mg2+)-ATPase and (Na(+)-K(+)-Mg2+)-ATPase. The (Ca(2+)-Mg2+)-ATPase of the erythrocyte membrane derived from human, rat, rabbit and pig were significantly stimulated.     

A derivative of bisbenzylisoquinoline alkaloid is a new and potential calmodulin antagonist

A new derivative of bisbenzylisoquinoline (berbamine type): 0-(4-ethoxylbutyl) berbamine (EBB) was found to possess powerful and specific calmodulin (CaM) inhibitory properties. It inhibited CaM-stimulated Ca2+-Mg2+-ATPase in human erythrocyte membrane with IC50 value of 0.35 microM compared to that of 60 microM of berbamine. CaM-independent basal Ca2+-Mg2+-ATPase, Na+-K+-ATPase and Mg2+-ATPase were not effect at 1.0 microM of EBB at which CaM-dependent Ca2+-Mg2+-ATPase was already potently inhibited. The inhibition of CaM-dependent Ca2+-Mg2+-ATPase was competitive with respect to CaM. Higher amount of CaM reversed the inhibition caused by higher concentration of EBB. Using dansyl-CaM (D-CaM), it was shown that EBB binds directly to CaM and caused a conformational change of CaM polypeptide chain. From fluorescence titration curve we obtained evidence that in the presence of Ca2+, CaM has two specific binding sites for EBB and additional unspecific binding sites. The Ca2+-dependent binding sites of EBB on CaM were novel region different from the binding sites for TFP.     

Effects of lanthanum on the heart sarcolemmal ATPase and calcium binding activities.

Effects of lanthanum on Ca2+-ATPase, Mg2+-ATPase, Na+-K+-ATPase, and calcium binding activities were studied in rat heart sarcolemma. Ten to 100 micrometers lanthanum depressed significantly the Ca2+-ATPase activity and 50--200 micrometers lanthanum inhibited the calcium binding activity. Lineweaver-Burk plots of the Ca2+-ATPase activity showed that the inhibition by lanthanum was competitive with calcium concentration. Neither Mg2+-ATPase nor Na+-K+-ATPase activities were affected by lanthanum when the assay medium contained 1 mM EDTA; however, in the absence of EDTA, these enzyme activities were significantly decreased by 10--100 micrometers lanthanum. Rat hearts perfused with HEPES buffer containing 0.5 mM lanthanum showed electron-dense deposits restricted to the outer cell surface and the sarcolemma obtained from these hearts also had the deposits, indicating that the membrane fraction isolated by the hypotonic shock--LiBr treatment method is of sarcolemmal origin. The Ca2+-ATPase activity of the sarcolemma isolated from lanthanum-perfused hearts, unlike the Mg2+-ATPase, Na+-K+-ATPase, and calcium binding activities, was significantly less than the control value. From these observations it is suggested that lanthanum may influence calcium movement across the sarcolemma by affecting sarcolemmal ATPase and calcium binding activities.     

In vivo studies on the toxic effects of microcystins on mitochondrial electron transport chain and ion regulation in liver and heart of rabbit

This study examined the toxic effects of microcystins on mitochondria of liver and heart of rabbit in vivo. Rabbits were injected i.p. with extracted microcystins (mainly MC-RR and -LR) at two doses, 12.5 and 50 MC-LReq. microg/kg bw, and the changes in mitochondria of liver and heart were studied at 1, 3, 12, 24 and 48 h after injection. MCs induced damage of mitochondrial morphology and lipid peroxidation in both liver and heart. MCs influenced respiratory activity through inhibiting NADH dehydrogenase and enhancing succinate dehydrogenase (SDH). MCs altered Na(+)-K(+)-ATPase and Ca(2+)-Mg(2+)-ATPase activities of mitochondria and consequently disrupted ionic homeostasis, which might be partly responsible for the loss of mitochondrial membrane potential (MMP). MCs were highly toxic to mitochondria with more serious damage in liver than in heart. Damage of mitochondria showed reduction at 48 h in the low dose group, suggesting that the low dose of MCs might have stimulated a compensatory response in the rabbits.     

Progress and problems in understanding the involvement of calcium in heart function

In this article we have briefly reviewed the role of Ca2+ in the excitation contraction coupling in the myocardium and have indicated that cardiac contraction and relaxation are initiated upon raising and lowering the intracellular concentration of free Ca2+, respectively. Different mechanisms for the entry of Ca2+ through sarcolemma as well as release of Ca2+ from sarcoplasmic reticulum and possibly mitochondria have been outlined for initiating cardiac contraction. Relaxation of the cardiac muscle appears to be intimately dependent upon efflux of Ca2+ through sarcolemma as well as sequestration of Ca2+ by the intracellular storage sites, particularly sarcoplasmic reticulum and possibly mitochondria. The actions of some pharmacological and pathophysiological interventions have been explained on the basis of changes in subcellular Ca2+ movements in myocardium. Quinidine, which produced an initial positive inotropic action on rat heart was also found to increase sarcolemmal Ca2+-ATPase activity without any changes in the Na+-K+ ATPase. Other antiarrhythmic agents, procainamide and lidocaine, also increased sarcolemmal Ca2+-ATPase activity without affecting the Na+-K+ ATPase. On the other hand, both Ca2+-ATPase and Na+-K+ ATPase activities were increased in heart sarcolemma obtained from cardiomyopathic hamsters. In this model the increased Ca2+-ATPase activity may promote the occurrence of intracellular Ca2+ overload in the cardiac cell whereas the increased Na+-K+ ATPase activity may increase Ca2+ efflux through Na+-Ca2+ exchange systems as an adaptive mechanism. It has been suggested that some caution should be exercised while interpreting the data from in vitro experiments in terms of functional changes in the myocardium. Furthermore, it has been proposed that the pathophysiology and pharmacology of Ca2+ movements at different membrane sites be understood fully in normal and diseased myocardium in order to improve the therapy of heart disease.     

Modification of sarcolemmal Na+-K+-ATPase and Na+/Ca2+ exchanger expression in heart failure by blockade of renin-angiotensin system

The activities of both sarcolemmal (SL) Na(+)-K(+)-ATPase and Na(+)/Ca(2+) exchanger, which maintain the intracellular cation homeostasis, have been shown to be depressed in heart failure due to myocardial infarction (MI). Because the renin-angiotensin system (RAS) is activated in heart failure, this study tested the hypothesis that attenuation of cardiac SL changes in congestive heart failure (CHF) by angiotensin-converting enzyme (ACE) inhibitors is associated with prevention of alterations in gene expression for SL Na(+)-K(+)-ATPase and Na(+)/Ca(2+) exchanger. CHF in rats due to MI was induced by occluding the coronary artery, and 3 wk later the animals were treated with an ACE inhibitor, imidapril (1 mg.kg(-1).day(-1)), for 4 wk. Heart dysfunction and cardiac hypertrophy in the infarcted animals were associated with depressed SL Na(+)-K(+)-ATPase and Na(+)/Ca(2+) exchange activities. Protein content and mRNA levels for Na(+)/Ca(2+) exchanger as well as Na(+)-K(+)-ATPase alpha(1)-, alpha(2)- and beta(1)-isoforms were depressed, whereas those for alpha(3)-isoform were increased in the failing heart. These changes in SL activities, protein content, and gene expression were attenuated by treating the infarcted animals with imidapril. The beneficial effects of imidapril treatment on heart function and cardiac hypertrophy as well as SL Na(+)-K(+)-ATPase and Na(+)/Ca(2+) exchange activities in the infarcted animals were simulated by enalapril, an ACE inhibitor, and losartan, an angiotensin receptor antagonist. These results suggest that blockade of RAS in CHF improves SL Na(+)-K(+)-ATPase and Na(+)/Ca(2+) exchange activities in the failing heart by preventing changes in gene expression for SL proteins.     

Glucose induces lipid peroxidation and inactivation of membrane-associated ion-transport enzymes in human erythrocytes in vivo and in vitro.

Erythrocytes of diabetic subjects (non-insulin dependent) were found to have eight- to ten-fold higher levels of endogenously formed thiobarbituric acid reactive malonyldialdehyde (MDA), thirteen-fold higher levels of phospholipid-MDA adduct, 15-20% reduced Na(+)-K(+)-ATPase activity with unchanged Ca+2-ATPase activity, as compared with the erythrocytes from normal healthy individuals. Incubation of normal erythrocytes with elevated concentrations (15-35 mM) of glucose, similar to that present in diabetic plasma, led to the increased lipid peroxidation, phospholipid-MDA adduct formation, reduction of Na(+)-K(+)-ATPase (25-50%) and Ca+2-ATPase (50%) activities. 2-doxy-glucose was 80% as effective as glucose in the lipid peroxidation and lipid adduct formation. However, other sugars, such as fructose, galactose, mannose, fucose, glucosamine and 3-O-methylmannoside, and sucrose, tested at a concentration of 35 mM, resulted in reduced (20-30%) lipid peroxidation without the formation of lipid-MDA adduct. Kinetic studies show that reductions in Na(+)-K(+)-ATPase and Ca+2-ATPase activities precede the lipid peroxidation as the enzyme inactivation occur within 30 min of incubation of erythrocytes with high concentration (15-35 mM) of glucose, while lipid peroxidation product, MDA appears at 4 hr and lipid-MDA adducts at 8 hr. The lipoxygenase pathway inhibitors, 5,8,11-eicosatriynoic acid and Baicalein (5,6,7-trihydroxyflavone), reduced the glucose-induced lipid peroxidation by 30% and MDA-lipid adduct formation by 26%. Indomethacin, a cyclooxygenase pathway inhibitor, had no discernible effect on the lipid peroxidation in erythrocytes. However, the inhibitors of lipid peroxidation, 3-phenylpyrazolidone, metyrapone, and the inhibitors of lipoxygenase pathways did not ablate the glucose-induced reduction of Na(+)-K(+)-ATPase and Ca+2-ATPase activities in erythrocytes. Erythrocytes produce 15-HETE (15-hydroxy-eicosatetraenoic acid), which is augmented by glucose. These results suggest that the formation of lipoxygenase metabolites potentiate the glucose-induced lipid peroxidation and that the inactivation of Na(+)-K(+)-ATPase and Ca+2-ATPase occurs as a result of non-covalent interaction of glucose with these enzymes.